No reason to cheer India drug verdict

Article Highlights

  • The is no guarantee that Indian companies can reproduce a drug that is as safe or effective as Gleevec

    Tweet This

  • The Indian Supreme Court dissuades foreign investment from working with Indian drug companies to improve drug quality

    Tweet This

  • Increasing access to medicines of uncertain quality is hardly a victory for public health

    Tweet This

The Indian Supreme Court’s decision on Gleevec will surely help some patients seeking affordable treatment (“US should tighten rules for patenting changes to drugs,” Editorial, April 8), but there is no guarantee that local companies can reproduce a drug that is as safe or effective as the original, especially when they have no data-sharing agreement with the company that designed it.

Quality assurance depends on India’s drug regulator, which is plagued with problems; a parliamentary report last year accused the agency of extensive corruption and misrepresentation of pharmaceutical drug data.

Foreign investments in India are one of the strongest tools to counteract these corrupt forces — by working hand-in-glove with Indian pharmaceutical companies and government agencies to improve oversight, information-sharing, management, and product quality. The court’s decision will discourage these investments.

That should be a concern for anyone celebrating the Gleevec decision. Increasing access to medicines of uncertain quality is hardly a victory for public health.

Dr. Roger Bate is a scholar at the American Enterprise Institute.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image The Census Bureau and Obamacare: Dumb decision? Yes. Conspiracy? No.
image A 'three-state solution' for Middle East peace
image Give the CBO long-range tools
image The coming collapse of India's communists
AEI on Facebook
Events Calendar
  • 14
    MON
  • 15
    TUE
  • 16
    WED
  • 17
    THU
  • 18
    FRI
Wednesday, April 16, 2014 | 10:00 a.m. – 11:00 a.m.
Calling treason by its name: A conversation with Liam Fox

Join us at AEI as the Right Honorable Liam Fox sits down with Marc Thiessen to discuss and debate whether America’s intelligence agencies have infringed on the personal privacy of US citizens.

Thursday, April 17, 2014 | 4:00 p.m. – 5:00 p.m.
The curmudgeon's guide to getting ahead

How can young people succeed in workplaces dominated by curmudgeons who are judging their every move? At this AEI book event, bestselling author and social scientist Charles Murray will offer indispensable advice for navigating the workplace, getting ahead, and living a fulfilling life.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.